Inhibition of adenovirus infection and adenain by green tea catechins

Balakirev, 2002, Deubiquitinating function of adenovirus proteinase, J. Virol., 76, 6323, 10.1128/JVI.76.12.6323-6331.2002 Cai, 2002, Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats, Drug Metab. Disposition, 30, 1246, 10.1124/dmd.30.11.1246 Cao, 1999, Angiogenesis inhibited by drinking tea, Nature, 398, 381, 10.1038/18793 Chen, 1998, Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts, Cancer Lett., 129, 173, 10.1016/S0304-3835(98)00108-6 Cornish, 1995, Specific inhibitors of the adenovirus type 2 protease based on substrate-like tetrapeptide nitrites, Bioorg. Med. Chem. Lett., 5, 25, 10.1016/0960-894X(94)00452-L De Clercq, 1993, Therapeutic potential of HPMPC as an antiviral drug, Rev. Med. Virol., 8, 261 De Clercq, 2000, Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection, Med. Res. Rev., 20, 323, 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A Demeule, 2000, Matrix metalloprotease inhibition by green tea catechins, Biochim. Biophys. Acta, 36094, 1 Ding, 1996, Crystal structure of the human adenovirus protease with its 11 amino acid cofactor, EMBO J., 15, 1778, 10.1002/j.1460-2075.1996.tb00526.x Diouri, 1995, Functional characterization of the adenovirus protease using fluorogenic substrates, Protein Peptide Lett., 6, 363, 10.2174/092986650202220524150013 Doronin, 2001, Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy, J. Virol., 75, 3314, 10.1128/JVI.75.7.3314-3324.2001 Garbisa, 1999, Tumor invasion: molecular shears blunted by green tea, Nat. Med., 5, 1216, 10.1038/15145 Garbisa, 2001, Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate, Cancer, 91, 822, 10.1002/1097-0142(20010215)91:4<822::AID-CNCR1070>3.0.CO;2-G Guo, 2000, Esterification of all-trans-retinol in normal human epithelial cell strains and carcinoma lines from oral cavity, skin and breast: reduced expression of lecithin:retinol acyltransferase in carcinoma lines, Carcinogenesis, 21, 1925, 10.1093/carcin/21.11.1925 Haneda, 2000, Biochemical characterization of casein kinase II as a protein kinase responsible for stimulation of HIV-1 protease in vitro, Biochem. Biophys. Res. Commun., 275, 434, 10.1006/bbrc.2000.3319 Horwitz, M. 1996. Adenoviruses. In: Fields, B.N. et al. (Eds.), Virology, vol.2. Lippincott-Raven, Philadelphia. Jankun, 1997, Why drinking green tea could prevent cancer?, Nature, 387, 561, 10.1038/42381 Keyvani-Amineh, 1995, Adenovirus protease expressed in insect cells cleaves adenovirus proteins, ovalbumin and baculovirus protease in the absence of activating peptide, Virus Res., 37, 87, 10.1016/0168-1702(95)00018-L Lee, 2002, Cancer Epidem. Biomarkers Prev., 11, 1025 Li, 1999, A new protease required for cell-cycle progression in yeast, Nature, 398, 246, 10.1038/18457 Lopez-Otin, 1989, Gly-Gly-X, a novel consensus sequence for the proteolytic processing of viral and cellular proteins, J. Biol. Chem., 264, 9107, 10.1016/S0021-9258(18)60496-X Mangel, 2001, A new form of antiviral combination therapy predicted to prevent resistance from arising and a model system to test it, Curr. Med. Chem., 8, 933, 10.2174/0929867013372742 Mentel, 1997, Inhibitory activity of 3′-fluoro-2′-deoxythymidine and related nucleoside analogues against adenoviruses in vitro, Antiviral Res., 34, 113, 10.1016/S0166-3542(97)01029-2 Mentel, 2000, Inhibition of adenovirus DNA polymerase by modified nucleoside triphosphate analogs correlate with their antiviral effects on cellular level, Med. Microbiol. Immunol., 189, 91, 10.1007/s004300000046 Mentel, 2000, Evaluation of the efficacy of 2′,3′-dideoxycytidine against adenovirus infection in a mouse pneumonia model, Antiviral Res., 47, 79, 10.1016/S0166-3542(00)00088-7 Morre, 2000, Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture, Biochem. Pharmacol., 60, 937, 10.1016/S0006-2952(00)00426-3 Mukhtar, 1999, Green tea in chemoprevention of cancer, Toxicol. Sci., 52, 111, 10.1093/toxsci/52.2.111 Nakayama, 1993, Inhibition of the infectivity of influenza virus by tea polyphenols, Antiviral Res., 21, 289, 10.1016/0166-3542(93)90008-7 Nevels, 2001, Hit-and-run transformation by adenovirus oncogenes, J. Virol., 75, 3089, 10.1128/JVI.75.7.3089-3094.2001 Pang, 2001, Discovery of a new inhibitor lead of adenovirus protease: steps toward selective, irreversible inhibitors of cysteine proteases, FEBS Lett., 502, 93, 10.1016/S0014-5793(01)02672-2 Precious, B., Russell, W.C., 1985. Growth, purification and titration of adenoviruses. In: Mahy, B.W.J. (Ed.), Virology: A Practical Approach. IRL, Oxford, England, pp. 193–205. Qualikene, 2000, Protease-deleted adenovirus vectors and complementing cell-lines: applications of single-round replication mutants for vaccination and gene therapy, Hum. Gene Ther., 11, 1341, 10.1089/10430340050032438 Ruzindana-Umunyana, 2000, The effect of mutant peptide cofactors on adenovirus protease activity and virus infection, Virology, 270, 173, 10.1006/viro.2000.0253 Ruzindana-Umunyana, 2001, Interactions of human lacrimal and salivary cystatins with adenovirus endopeptidase, Antiviral Res., 51, 203, 10.1016/S0166-3542(01)00154-1 Sachinidis, 2000, Green tea compounds inhibit tyrosine phosphorylation of PDGF β-receptor and transformation of A172 human glioblastoma, FEBS Lett., 471, 51, 10.1016/S0014-5793(00)01360-0 Sircar, 1996, Inhibition of adenovirus infection with protease inhibitors, Antiviral Res., 30, 147, 10.1016/0166-3542(95)06939-9 Sircar, 1998, Adenovirus endopeptidase and papain are inhibited by same agents, Antiviral Res., 40, 45, 10.1016/S0166-3542(98)00040-0 Weber, J.M. 1999. Role of endopeptidase in adenovirus infection. In: P. Seth (Ed.), Adenoviruses: From Basic Research to Gene Therapy Application. R.G. Landes Company. Whickam, 2000, Targeting adenovirus, Gene Ther., 7, 110, 10.1038/sj.gt.3301115 Williams, 2000, Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression, Chemico-Biol. Interact., 128, 211, 10.1016/S0009-2797(00)00204-0 Yamaguchi, 2002, Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1), Antiviral Res., 53, 19, 10.1016/S0166-3542(01)00189-9 Yang, 1998, Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers, Cancer Epidem. Biomarkers Prev., 7, 351 Yang, 1998, Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols, Carcinogenesis, 19, 611, 10.1093/carcin/19.4.611 Yang, 1993, Tea and cancer, J. Natl. Cancer Inst., 85, 1038, 10.1093/jnci/85.13.1038